---

Market Overview

---

The global breast implants market surpassed USD 2.52 billion in 2022 and is expected to double in value by 2028, with an estimated compound annual growth rate (CAGR) of 6.99%. One of the primary drivers of this growth is the global demand for breast augmentation and the increasing prevalence of breast cancer. Breast augmentation is primarily pursued to enhance breast size and volume, influenced by societal factors such as social media, fashion trends, and the film industry. In developing countries, affordable prices and advanced cosmetic surgery services are key factors driving the growth of the breast implants market. Medical tourism also contributes to the industry’s expansion, with many European patients traveling to countries like Turkey, India, and Latin American nations for breast implant surgery due to lower costs.

Breast cancer has become the most diagnosed cancer worldwide, surpassing lung cancer, according to the World Health Organization (WHO). In 2020, approximately 2.3 million women were diagnosed with breast cancer globally, resulting in 685,000 deaths. In Asian women, breast cancer accounted for 22.9% of all cancer cases in 2020. The United States alone has over 3.8 million women with a history of breast cancer as of January 2022, including those currently undergoing treatment or finished with it. Breast cancer represents 12% of all new cancer cases globally as of 2021. These factors are expected to drive the growth of the breast implants market during the forecast period, as breast augmentation and reconstruction procedures, including breast implant revision surgery, continue to rise.

The rapid acceptance of minimally invasive breast augmentation, specifically transaxillary breast augmentation, is anticipated to significantly contribute to market growth. This technique, performed under the armpit, has revolutionized the breast implants market due to the inconspicuous scarring associated with it. Transaxillary breast augmentation has gained popularity in recent years. Its growth can be attributed to the lower risk of scarring involved.

The prevalence of breast cancer among females worldwide continues to increase, driving the demand for implant-based breast reconstruction procedures. In India alone, the breast cancer rate has reached almost 13.5%, according to the GLOBOCAN 2020 survey. Countries like Indonesia, Singapore, and Malaysia have the highest breast cancer death rates in the Asia-Pacific region. Consequently, the rising mastectomy rate in the region fuels the growth of the breast implant market.

Social and cultural influences, including media, the film industry, peer pressure for appearance, and evolving beauty standards, are significant drivers of the breast implants market. They have led to an increase in the number of cosmetic surgery facilities worldwide. For example, in 2020, $16.7 billion was spent on cosmetic procedures in the US alone, according to the American Society of Plastic Surgeons (ASPS). Social media and online platforms play a critical role in making women aware of trending cosmetic surgeries. This online presence enables individuals to access information about health procedures and surgeries more easily. Therefore, with the rise of social media, the cosmetic surgery industry is experiencing substantial growth.

---

Market Segmentation

---

The market is segmented based on various factors, including product, shape, surface, application, end-user, and geography.

Segmentation By Product
Silicone
Saline

Segmentation By Shape
Round
Anatomical

Segmentation By Surface
Smooth
Textured

Segmentation By Application
Breast Augmentation
Breast Reconstruction

Segmentation By End-User
Hospitals
Cosmetology Clinics
Others

Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain, Russia
APAC – China, India, South Korea, Thailand, Malaysia, The Philippines
Latin America – Brazil, Mexico, Argentina, Colombia
Middle East & Africa -Saudi Arabia, UAE, Turkey, Egypt, Iran

In 2022, the silicone segment held the largest revenue share, accounting for 81.96% of the global breast implants market. It is projected to grow at a compound annual growth rate (CAGR) of 7.27%. This dominance can be attributed to the soft and natural texture of silicone implants, which closely resemble natural breast tissues. One recent advancement in silicone implants is the gummy bear implant, which offers a more natural shape to reconstructed breasts and is considered safer than traditional options. Moreover, silicone implants have a lower risk for immune system disorders and are less likely to cause hard scar tissue formation. In the United States, all silicone implants are made of cohesive gel, a thicker type of silicone.

Saline breast implants are also expected to experience significant growth during the forecast period due to their lower risk of complications and associated risks in case of implant rupture. The global saline breast implants market was valued at USD 456 million in 2022. However, the adoption of saline implants is relatively low as they are more easily visible under the skin and can give a sensation of water sloshing. Nonetheless, saline implants remain popular in many countries due to their affordability.

The round segment accounted for the highest revenue share in 2022, comprising 81.96% of the global breast implants market. This is because round implants provide a fuller and more voluminous look, making them ideal for breast augmentation. However, anatomical implants are expected to grow at a faster pace, with a CAGR of 9.48%, as they mimic the natural shape of breasts. They are recommended for women with insufficient breast tissue or smaller builds, who prefer a more natural teardrop shape. Anatomical implants are also highly favored in breast reconstructive surgeries.

Smooth breast implants accounted for the highest revenue share in the global market and are projected to grow at the highest CAGR of 7.72% during the forecast period. These implants are more popular because they last longer than textured implants and have a lower risk of rippling and leaking. Many plastic surgeons prefer to use smooth implants for these reasons. Additionally, smooth implants have not shown any association with cancer and are considered safe for use.

On the other hand, textured implants, which have been strongly linked to breast implant-associated cancer, are expected to decline with a CAGR of 12.93% during the forecast period. Leading manufacturer Allergan (AbbVie) recalled their textured implants globally in 2019, resulting in significantly reduced preference among plastic surgeons. Textured implants have a rough surface that promotes scar tissue formation and adherence to breast tissue, reducing the likelihood of implant displacement. They can be either round or teardrop-shaped, with teardrop-shaped implants requiring a textured shell for better adhesion.

Breast augmentation procedures dominate the global breast implants market. The demand for breast augmentation is increasing due to its ability to improve saggy breasts in older women and enhance the appearance of breasts in younger women. Breast augmentation is projected to grow at a CAGR of 7.40% during the forecast period, primarily driven by the rising demand among women aged 20-35. Emerging economies like Brazil, Mexico, and India present significant opportunities for breast augmentation procedures due to the rapid growth of medical tourism and increased disposable incomes.

The global breast reconstruction market was valued at USD 567 million in 2022 and is expected to witness impressive growth by 2028. Breast reconstruction is commonly performed on women who have undergone mastectomy. In the US, immediate reconstruction is the most common practice, chosen by approximately 75% of patients. The increasing prevalence of mastectomy procedures and breast cancer is driving the growth of the breast implants market. According to the American Society of Plastic Surgeons (ASPS), approximately 101,600 women in the US underwent breast reconstruction in 2018, accounting for more than 40% of women who underwent mastectomy.

Hospitals are the largest end-users in the breast implants market due to surgeons’ preference for hospital-based treatments. In 2020, hospitals accounted for about 43.80% of cosmetic procedures, followed by cosmetology clinics (32.40%) and other settings such as ambulatory care and academic institutes (23.8%), according to the International Society of Aesthetic Plastic Surgery (ISAPS) report. Nevertheless, cosmetology clinics are expected to grow at the highest CAGR of 7.44% owing to their convenience, lower patient volumes, discounted prices, and availability of trained and experienced cosmetic surgeons. The youth, particularly millennials and Generation Z, have greater disposable income to spend on their appearance, and the popularity of cosmetic surgeries in cosmetology clinics has surged with the widespread use of social media.

North America held the largest market share in the global breast implants market in 2022, accounting for 25.40%. This can be attributed to the region’s strong inclination toward aesthetic surgeries and a high demand for enhancing aesthetic appeal. The United States leads in the utilization of smooth breast implants, while textured implants are more preferred in Europe. North America is also home to established market players such as AbbVie, Johnson & Johnson, and Sientra, who focus on developing new products and opening growth avenues for the industry.

The Europe breast implants market was valued at USD 594 million in 2022. Market growth in this region is driven by advancements in medical aesthetic devices, the affordability of treatments, a large population of aging individuals, millennials, and Generation X, increased internet and social media usage, and the introduction of new cosmetic procedures and anti-aging therapies. The rising prevalence of breast cancer is also expected to contribute to market growth.

Latin America and the Asia-Pacific (APAC) regions are projected to show lucrative growth with the highest CAGR of 8.77% and 7.91%, respectively, due to low-cost treatments and high medical tourism. Increased disposable income in various emerging APAC countries, along with a growing consciousness regarding body appearance and increased incidence of breast cancer, will drive market growth in these regions over the forecast period.

---

Competitive Landscape

---

The global breast implants market is characterized by a duopoly and is highly dynamic, with moderate levels of competition. There are several international, regional, and local vendors that offer a diverse range of breast implants for applications in both breast augmentation and reconstruction procedures. The market is dominated by two major companies, AbbVie and Johnson & Johnson, which hold a duopoly position. However, other key players are expected to compete on an equal footing with these leading companies in the coming years.

The market is experiencing a surge in innovations and investments as companies focus on the development of new breast implants. This has led to the entry of new players into the market, and there have been numerous product launches in recent years.

Competition in this market is expected to intensify during the forecast period. Leading players have extensive product portfolios for both applications and are actively expanding their global distribution networks to explore untapped opportunities. Additionally, significant investments and funding from conglomerates and investment firms are fueling product development in the global breast implants market. Mergers and acquisitions also play a crucial role in facilitating the growth of companies in this industry. Global players are anticipated to expand their presence in the market, particularly in terms of quality, features, and pricing.

Key companies profiled in this report include AbbVie, Johnson & Johnson, Sientra, Establishment Labs, POLYTECH Health & Aesthetics, GC Aesthetics, Hans Biomed, IDEAL IMPLANT, Laboratoires Arion, Sebbin, Silimed.

---

Recent Industry Developments

---

In March 2022, Sientra, a prominent company in the global breast implants market, obtained approval from Health Canada to commercially distribute its smooth round high strength cohesive (HSC) and high strength cohesive plus (HSC+) silicone gel breast implants in Canada. This approval was granted in partnership with its distribution partner, Kai Aesthetics. In September 2022, the same breast implants received regulatory approval for commercialization in Saudi Arabia.

On January 4, 2023, CollPlant announced successful pre-clinical results for its 3D bioprinted regenerative breast implants porcine study. These results showcased progressive stages of tissue regeneration within the implants, as evidenced by the formation of maturing connective tissue and neovascular networks. Importantly, no adverse reactions were observed during the study.

In 2022, Australian scientists achieved a significant breakthrough in the field of breast implants by utilizing additive manufacturing technology. They successfully produced scaffolds that have the potential to replace conventional silicone breast implants in the future. The scaffold is designed to resemble a traditional breast implant and is constructed using the same material employed in dissolvable stitches.

---

Key Questions Answered

---

What is the size of the global breast implants market?

The global breast implants market was valued at USD 2.52 billion in 2022 and is projected to reach USD 3.79 billion by 2028.

What is the growth rate of the breast implants market?

The breast implants market is expected to grow at a compound annual growth rate (CAGR) of 6.99% from 2022 to 2028.

What are the emerging trends in the breast implants market?

Some of the emerging trends in the global breast implants market include the increasing demand for gummy-bear implants, advancements in breast implant technologies, and the rising popularity of minimally invasive procedures.

Which region holds the largest market share in the global breast implants market?

North America held the largest market share in the global breast implants market, accounting for 25.40% in 2022.

Who are the major players in the global breast implants market?

The key players in the global breast implants market include AbbVie, Johnson & Johnson, Sientra, Establishment Labs, POLYTECH Health & Aesthetics, and GC Aesthetics.

Which type of breast implant dominates the global market?

Round breast implants contribute the largest revenue share in the global breast implants market. Their round shape makes them ideal for breast augmentation procedures.